HUE059596T2 - Agydaganat kezelésének módszere és készlete ultrahangos rendszer segítségével - Google Patents

Agydaganat kezelésének módszere és készlete ultrahangos rendszer segítségével

Info

Publication number
HUE059596T2
HUE059596T2 HUE16863657A HUE16863657A HUE059596T2 HU E059596 T2 HUE059596 T2 HU E059596T2 HU E16863657 A HUE16863657 A HU E16863657A HU E16863657 A HUE16863657 A HU E16863657A HU E059596 T2 HUE059596 T2 HU E059596T2
Authority
HU
Hungary
Prior art keywords
kit
brain tumor
ultrasound system
treating brain
treating
Prior art date
Application number
HUE16863657A
Other languages
English (en)
Inventor
Hao-Li Liu
Po-Chun Chu
Ting-Kuang Chang
Kuo-Chen Wei
Pin-Yuan Chen
Chiung-Yin Huang
Original Assignee
Navifus Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Navifus Co Ltd filed Critical Navifus Co Ltd
Publication of HUE059596T2 publication Critical patent/HUE059596T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37—Surgical systems with images on a monitor during operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0004—Applications of ultrasound therapy
    • A61N2007/0021—Neural system treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0039—Ultrasound therapy using microbubbles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HUE16863657A 2015-11-11 2016-11-10 Agydaganat kezelésének módszere és készlete ultrahangos rendszer segítségével HUE059596T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562253805P 2015-11-11 2015-11-11

Publications (1)

Publication Number Publication Date
HUE059596T2 true HUE059596T2 (hu) 2022-12-28

Family

ID=58694540

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16863657A HUE059596T2 (hu) 2015-11-11 2016-11-10 Agydaganat kezelésének módszere és készlete ultrahangos rendszer segítségével

Country Status (12)

Country Link
US (1) US20210106849A1 (hu)
EP (1) EP3374024B1 (hu)
JP (1) JP7053463B2 (hu)
CN (1) CN108430579B (hu)
AU (1) AU2016354728B2 (hu)
DK (1) DK3374024T3 (hu)
ES (1) ES2925002T3 (hu)
HK (1) HK1256135A1 (hu)
HU (1) HUE059596T2 (hu)
PL (1) PL3374024T3 (hu)
TW (1) TWI751122B (hu)
WO (1) WO2017080481A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107864633A (zh) 2014-12-19 2018-03-30 皮埃尔与玛丽·居里-巴黎第六大学 用于脑治疗的可植入的超声发生治疗装置、包括此装置的设备以及实施此装置的方法
WO2017153799A1 (en) 2016-03-11 2017-09-14 Universite Pierre Et Marie Curie (Paris 6) External ultrasound generating treating device for spinal cord and spinal nerves treatment, apparatus comprising such device and method implementing such device
WO2017153798A1 (en) 2016-03-11 2017-09-14 Université Pierre Et Marie Curie (Paris 6) Implantable ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method
US20210253739A1 (en) * 2018-08-23 2021-08-19 Siwa Corporation Anticarboxymethyl lysine antibodies and ultrasound for removing age-modified cells
WO2020211076A1 (zh) * 2019-04-19 2020-10-22 深圳先进技术研究院 一种实现超声穿颅聚焦的方法以及电子设备
GB2605422A (en) * 2021-03-31 2022-10-05 Act Therapeutics Ltd Treatment of the central nervous system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5752515A (en) * 1996-08-21 1998-05-19 Brigham & Women's Hospital Methods and apparatus for image-guided ultrasound delivery of compounds through the blood-brain barrier
US7896821B1 (en) * 2003-11-14 2011-03-01 Perfusion Technology, LLC Low intensity directed ultrasound (LODUS) mediated blood brain barrier disruption
US7674229B2 (en) * 2005-03-07 2010-03-09 The Brigham And Women's Hospital, Inc. Adaptive ultrasound delivery system
EP1986632B1 (en) * 2006-02-10 2012-08-15 Nerviano Medical Sciences S.R.L. Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
TWI382860B (zh) * 2008-07-11 2013-01-21 Univ Chang Gung 非侵入式低頻超音波腦部治療裝置及其使用方法
JP5689416B2 (ja) * 2008-07-23 2015-03-25 コーニンクレッカ フィリップス エヌ ヴェ 超音波仲介による薬送達
US20100143241A1 (en) * 2008-10-22 2010-06-10 Johnson G Allan Method and apparatus for delivery of agents across the blood brain barrier
WO2011101039A1 (en) * 2010-02-22 2011-08-25 Universite Pierre Et Marie Curie (Paris 6) Apparatus for the treatment of brain affections and method implementing thereof
EP2600777A1 (en) * 2010-08-05 2013-06-12 The Trustees of Columbia University in the City of New York Systems, methods, and devices for ultrasonic assessment of cancer and response to therapy
US20120095325A1 (en) * 2010-10-15 2012-04-19 Chang Gung Medical Foundation, Linkou Branch Treatment of brain diseases via ultrasound/magnetic targeting delivery and tracing of therapeutic agents
GB201019434D0 (en) * 2010-11-17 2010-12-29 Isis Innovation Sonosensitive nanoparticles
WO2012076582A1 (en) * 2010-12-09 2012-06-14 F. Hoffmann-La Roche Ag Agtr1 as a marker for bevacizumab combination therapies
EP2768386B1 (en) * 2011-10-19 2024-04-03 Tel HaShomer Medical Research Infrastructure and Services Ltd. Magnetic resonance maps for analyzing tissue
CN102525935A (zh) * 2012-01-18 2012-07-04 上海交通大学医学院 一种纳米药物载体脑内递送方法
EP4005604B8 (en) * 2013-09-27 2023-07-19 Exact Therapeutics As Delivery of drugs
WO2015192189A1 (en) * 2014-06-20 2015-12-23 The University Of Queensland Neurodegenerative disease treatment

Also Published As

Publication number Publication date
JP7053463B2 (ja) 2022-04-12
AU2016354728A1 (en) 2018-05-24
EP3374024B1 (en) 2022-07-13
US20210106849A1 (en) 2021-04-15
TW201729866A (zh) 2017-09-01
HK1256135A1 (zh) 2019-09-13
EP3374024A4 (en) 2019-06-19
ES2925002T3 (es) 2022-10-13
AU2016354728B2 (en) 2019-02-28
DK3374024T3 (da) 2022-08-15
PL3374024T3 (pl) 2022-12-12
WO2017080481A1 (en) 2017-05-18
EP3374024A1 (en) 2018-09-19
JP2019502657A (ja) 2019-01-31
TWI751122B (zh) 2022-01-01
CN108430579A (zh) 2018-08-21
CN108430579B (zh) 2021-02-05

Similar Documents

Publication Publication Date Title
ZA201705673B (en) Methods for treating skin
IL250329A0 (en) System and method for optogenetic therapy
HK1244293A1 (zh) 用cd3xcd20雙特異性抗體治療腫瘤的方法
ZA201701491B (en) Methods and therapeutic combinations for treating tumors
ZA201706616B (en) Method for treating cancer
SG10201913409VA (en) Methods for solid tumor treatment
IL257691A (en) A method for treating cancer
HK1256135A1 (zh) 通過使用超聲系統治療腦腫瘤的方法和試劑盒
HK1254258A1 (zh) 使用阿吡莫德治療癌症的方法
HK1250248A1 (zh) 鞣製動物皮的方法
IL254014A0 (en) System and method for water treatment
GB2537603B (en) Method and apparatus for water treatment
SG10201508795XA (en) Method for treating cancer
ZA202001927B (en) Method for treating tnf alpha-related diseases
IL255012A0 (en) Preparations and methods for treating skin conditions
ZA201607027B (en) Method for treating or enhancing muscle tissue
GB2594828B (en) Method and apparatus for water treatment
GB201501202D0 (en) Novel methods for diagnosis and therapy